Company Monitoring Page for Regeneron

latest headlines for company on cafepharma

20 Biotech Stocks Being Bought Up By Hedge Funds
Seeking Alpha
Sun, 03/25/12 - 11:38 am
Tags:
Achillion, Amylin, Ariad Pharmaceuticals, Aveo Pharmaceutical, Cell Therapeutics, EXACT Sciences, Idenix, Exelixis, Halozyme, Lexicon Pharmaceuticals, Nektar, Momenta, ONYX Pharmaceuticals, Optimer Pharmaceuticals, PDL Biopharma, Questcor Pharmaceuticals, Santarus, Spectrum Pharmaceuticals, Regeneron, Vivus
Next big cholesterol drugs in focus at meeting
Reuters
Thu, 03/22/12 - 11:28 am
Tags:
cardiology, PCSK9 inhibitor, REGN 727, Amgen, Merck, Regeneron
A Drug Class Back From the Dead?
Motley Fool
Wed, 03/14/12 - 09:42 am
Tags:
Pfizer, Regeneron, JNJ, Sanofi, AstraZeneca, FDA, NGF blockers
Don't Expect Too Much From New Pain Drugs, Analyst Says
Forbes
Tue, 03/13/12 - 11:07 am
Tags:
painkillers, NGF blockers, Amgen, Regeneron, JNJ
FDA panel recommends lifting research hold on nerve-blocking pain drugs, despite safety risk
Yahoo/AP
Mon, 03/12/12 - 05:47 pm
Tags:
FDA, painkillers, Pfizer, JNJ, Regeneron, arthritis
U.S. Regulators Probes Resuming Painkiller Trials Tied to Joint Failure
Bloomberg
Thu, 03/8/12 - 09:55 am
Tags:
Pfizer, JNJ, FDA, joint failure, painkillers, fulranumab, Sanofi, Regeneron, tanezumab, REGN475/SAR164877
1-Star Stocks Poised to Plunge: Regeneron?
Motley Fool
Thu, 02/16/12 - 11:21 am
Tags:
Regeneron
Regeneron climbs after raising Eylea sales outlook
Yahoo/AP
Mon, 02/13/12 - 08:01 pm
Tags:
Regeneron, Eylea
6 Drug Stocks Unworthy of Biotech Bull Market
TheStreet.com
Tue, 02/7/12 - 10:49 am
Tags:
Cytori, Regeneron, Human Genome Sciences, Galena Biopharma, BioSante, EntreMed
3 Lessons From the J.P. Morgan Health-Care Confab
Motley Fool
Mon, 01/16/12 - 10:43 am
Tags:
SOMA, Regeneron, Vertex, Gilead, GSK, Biocryst, Dendreon, InterMune
Biotechs: Has The Law Of Gravity Been Suspended?
Seeking Alpha
Sat, 01/14/12 - 11:27 am
Tags:
Celgene, Dendreon, Medivation, Regeneron, ViroPharma
Biotech Investors Buoyed By Signs Of Speedier Drug Launches
Seeking Alpha
Mon, 01/9/12 - 10:40 am
Tags:
drug launches, Dendreon, Incyte, Human Genome Sciences, Regeneron, Seattle Genetics, Vertex
Dendreon, JAZZ and Regeneron Among Best Stock Price Performers
Yahoo/Wall St. Cheat Sheet
Sat, 01/7/12 - 01:26 pm
Tags:
Dendreon, Jazz, Regeneron
Biotech 2012 Kickoff Party: Investor Preview
TheStreet.com
Wed, 01/4/12 - 10:22 am
Tags:
Celgene, Vivus, Dendreon, Gilead, Incyte, YM BioSciences, ONYX Pharmaceuticals, Seattle Genetics, Vertex, Amarin, Biomarin, Biogen Idec, Regeneron, Merck KGaA, Human Genome Sciences, Clovis Oncology, Roche, Ariad, Immunogen, Medivation, Geron, InterMune, Indenix, Amag Pharmaceuticals, Mesoblast, Arena, MannKind, Keryx, Spectrum Pharmaceuticals
Regeneron settles with Genentech over eye drug
Yahoo/AP
Tue, 01/3/12 - 11:29 am
Tags:
Regeneron, Genentech, Eyelea
Pharma winners of 2011 could keep surging next year
Investorplace
Wed, 12/28/11 - 12:08 pm
Tags:
Amgen, Biogen Idec, Celgene, Gilead, Pharmasset, Alexion, Regeneron
Regeneron Drops as Eye Drug Shown Similar to Roche's Lucentis
Bloomberg Businessweek
Mon, 12/5/11 - 12:28 pm
Tags:
Roche, Lucentis, Regeneron, Eyela, wet-AMD
December Catalysts for Drug and Biotech Stocks
Minyanville
Sat, 12/3/11 - 11:11 am
Tags:
Pfizer, Aveo Pharmaceutical, Affymax, Amgen, Antares Pharma, Celgene, ONYX Pharmaceuticals, Seattle Genetics, Micromet, YM BioSciences, Regeneron, BioSante
Regeneron Pharma and Bayer begin late-stage trial of eye drug Eylea in China
Yahoo/AP
Mon, 11/28/11 - 11:41 am
Tags:
Regeneron, Bayer, Eyelea, China, retinal disease
This Biotech Has Almost Everything Going for It
Motley Fool
Mon, 11/21/11 - 06:28 pm
Tags:
Eyelea, Regeneron

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.